Medtronic PLC MDT
88.64
0.13
0.15%
as of 25 Sep
- Market cap
- $112.2B
- P/E
- 21.7×
Follow MDT
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
Medtronic PLC (MDT) Current ratio
Medtronic PLC's current ratio at the end of the quarter to 31 July 2026 was 2.1×, down 0.1× from fiscal 2026 (2.1×). Over the past ten years it has ranged from 1.7× (fiscal 2017) to 3.4× (fiscal 2015); the current reading is higher than 50% of that period. That is below the Medical Devices industry median of 2.5× and below the Healthcare sector median of 3.0×.
Current ratio, annual
Annual
| Period | Current ratio | Change |
|---|---|---|
| FY2026 | 2.1× | 14.99% |
| FY2025 | 1.8× | (9.05%) |
| FY2024 | 2.0× | (15.10%) |
| FY2023 | 2.4× | 28.72% |
| FY2022 | 1.9× | (29.79%) |
| FY2021 | 2.6× | 24.68% |
| FY2020 | 2.1× | (18.03%) |
| FY2019 | 2.6× | 13.78% |
| FY2018 | 2.3× | 30.69% |
| FY2017 | 1.7× | (47.06%) |
Quarterly
| Period | Current ratio | Change |
|---|---|---|
| Jul 2026 | 2.1× | (2.78%) |
| Apr 2026 | 2.1× | (16.13%) |
| Jan 2026 | 2.5× | 4.96% |
| Oct 2025 | 2.4× | 19.92% |
| 43 more quarters | Free account |
Against its own ten years
Low 1.7×
High 3.4×
Ten-year median
2.2×
Current reading's percentile
50
Current ratio against peers
| Company | Current ratio |
|---|---|
| EW Edwards Lifesciences Corporation compare | 4.5× |
| SYK Stryker Corporation compare | 2.2× |
| MDT Medtronic PLC | 2.1× |
| STE STERIS plc compare | 1.9× |
| DXCM DexCom, Inc. compare | 1.7× |
| ABT Abbott Laboratories compare | 1.4× |
| GEHC GE HealthCare Technologies Inc. compare | 1.3× |
| PHG Koninklijke Philips N.V. compare | 1.3× |
| BSX Boston Scientific Corporation compare | 1.2× |
| Medical Devices industry median | 2.5× |
| Healthcare sector median | 3.0× |
| Market median | 1.6× |
What Current ratio is
Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.
Current Assets (Total) ÷ Current Liabilities (Total)
More on MDT
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement